Published in Med Clin (Barc) on May 12, 2007
[Staphylococcus aureus bacteremia. Mortality and resistance to methicillin]. Med Clin (Barc) (2007) 0.75
Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent (COMPARE II): a randomised, controlled, non-inferiority trial. Lancet (2013) 2.81
Left atrial appendage closure with Amplatzer cardiac plug in atrial fibrillation: initial European experience. Catheter Cardiovasc Interv (2011) 2.67
[The implantable cardioverter-defibrillator and hypertrophic cardiomyopathy. Experience at three centers]. Rev Esp Cardiol (2006) 2.63
Statins and postoperative risk of atrial fibrillation following coronary artery bypass grafting. Am J Cardiol (2005) 2.47
Open vs laparoscopic repair of spigelian hernia: a prospective randomized trial. Arch Surg (2002) 2.42
Role of microRNAs in cardiac remodelling: new insights and future perspectives. Int J Cardiol (2012) 2.32
Should we recommend oral anticoagulation therapy in patients with atrial fibrillation undergoing coronary artery stenting with a high HAS-BLED bleeding risk score? Circ Cardiovasc Interv (2012) 2.07
Long-term results of a randomized prospective study comparing medical and surgical treatment of Barrett's esophagus. Ann Surg (2003) 2.03
Prospective study of postoperative complications after total thyroidectomy for multinodular goiters by surgeons with experience in endocrine surgery. Ann Surg (2004) 1.98
Soluble ST2, high-sensitivity troponin T- and N-terminal pro-B-type natriuretic peptide: complementary role for risk stratification in acutely decompensated heart failure. Eur J Heart Fail (2011) 1.92
Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis. J Am Coll Cardiol (2008) 1.89
Usefulness of clinical and NT-proBNP monitoring for prognostic guidance in destabilized heart failure outpatients. Eur Heart J (2008) 1.75
The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation. J Am Coll Cardiol (2013) 1.72
Fluoroquinolones vs macrolides in the treatment of Legionnaires disease. Chest (2005) 1.69
Plasma von Willebrand factor levels are an independent risk factor for adverse events including mortality and major bleeding in anticoagulated atrial fibrillation patients. J Am Coll Cardiol (2011) 1.67
Outpatient laparoscopic incisional/ventral hernioplasty: our experience in 55 cases. Surg Laparosc Endosc Percutan Tech (2002) 1.63
[Clinical utilization of the coronary pressure wire]. Rev Esp Cardiol (2002) 1.56
Human thrombin for treatment of pseudoaneurysms: comparison of bovine and human thrombin sonogram-guided injection. AJR Am J Roentgenol (2005) 1.50
Red blood cell distribution width adds prognostic value for outpatients with chronic heart failure. Rev Esp Cardiol (Engl Ed) (2012) 1.49
Influence of CYP2C19 polymorphisms in platelet reactivity and prognosis in an unselected population of non ST elevation acute coronary syndrome. Rev Esp Cardiol (Engl Ed) (2011) 1.46
Pulmonary surfactant protein B in the peripheral circulation and functional impairment in patients with chronic heart failure. Rev Esp Cardiol (2009) 1.46
[Intracoronary stem cell transplantation in acute myocardial infarction]. Rev Esp Cardiol (2004) 1.44
Mild kidney disease as a risk factor for major bleeding in patients with atrial fibrillation undergoing percutaneous coronary stenting. Thromb Haemost (2011) 1.43
[Treatment of acute myocardial infarction by primary angioplasty on-site compared with treatment following interhospital transfer: short- and long-time clinical outcomes]. Rev Esp Cardiol (2007) 1.41
Does pacemaker implantation provide long-term benefits in severe obstructive hypertrophic cardiomyopathy? Rev Esp Cardiol (2009) 1.41
[Comparative prognostic value of plasma and urinary N-terminal pro-B-type natriuretic peptide in patients with acute destabilized heart failure]. Rev Esp Cardiol (2011) 1.39
Associations of HLA-C alleles with multinodular goiters: study in a population from southeastern Spain. Arch Surg (2006) 1.39
[Troponin-T monitoring in outpatients with nonischemic heart failure]. Rev Esp Cardiol (2008) 1.39
Characteristics of sudden death in inherited heart disease. Rev Esp Cardiol (2010) 1.39
[Direct Stenting without Predilation: a Single-Center Experience with 1,000 Lesions]. Rev Esp Cardiol (2002) 1.39
Influence of aortic regurgitation after TAVI on left ventricular filling pattern. Eur J Clin Invest (2015) 1.38
Legionnaires' disease outbreak in Murcia, Spain. Emerg Infect Dis (2003) 1.38
[Infections in joint prostheses: epidemiology and clinical presentation. A prospective study 1992-1999]. Enferm Infecc Microbiol Clin (2002) 1.38
Soluble ST2 for predicting sudden cardiac death in patients with chronic heart failure and left ventricular systolic dysfunction. J Am Coll Cardiol (2009) 1.35
Brugada-like electrocardiographic pattern induced by fever. Pacing Clin Electrophysiol (2002) 1.15
[Use of a coronary risk score (the TIMI Risk Score) in a non-selected patient population assessed for chest pain at an emergency department]. Rev Esp Cardiol (2005) 1.13
Utility of the fractional flow reserve in the evaluation of angiographically moderate in-stent restenosis. Eur Heart J (2004) 1.12
Plasma levels of von Willebrand factor are increased in patients with hypertrophic cardiomyopathy. Thromb Res (2010) 1.08
[Program of coronary angioplasty in acute myocardial infarction in the region of Murcia (Spain). APRIMUR Registry]. Rev Esp Cardiol (2002) 1.07
[Short- and medium-term outcomes of percutaneous coronary intervention for unprotected left main coronary artery disease in patients who are poor candidates for surgical revascularization]. Rev Esp Cardiol (2004) 1.07
[Time intervals in primary angioplasty from onset of symptoms until restoration of blood flow]. Rev Esp Cardiol (2002) 1.07
Surgical management of multinodular goiter with compression symptoms. Arch Surg (2005) 1.04
Cytotoxicity and antiproliferative activities of several phenolic compounds against three melanocytes cell lines: relationship between structure and activity. Nutr Cancer (2004) 1.03
Renal impairment in a "real-life" cohort of anticoagulated patients with atrial fibrillation (implications for thromboembolism and bleeding). Am J Cardiol (2013) 1.02
Effectiveness of cognitive-behavioral therapy based on the Mediterranean diet for the treatment of obesity. Nutrition (2009) 1.02
Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation. Thromb Haemost (2013) 1.02
Utility of fine-needle aspiration for diagnosis of carcinoma associated with multinodular goitre. Clin Endocrinol (Oxf) (2004) 0.98
Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation. Circ Arrhythm Electrophysiol (2012) 0.97
Small-size circulating microparticles in acute coronary syndromes: relevance to fibrinolytic status, reparative markers and outcomes. Atherosclerosis (2013) 0.97
Socio-personal profile of teenagers opposed to organ donation. Nephrol Dial Transplant (2004) 0.95
Two-dimensional predictive equation to classify visceral obesity in clinical practice. Obesity (Silver Spring) (2006) 0.95
Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy. Am Heart J (2008) 0.95
Biomarkers of pathophysiology in hypertrophic cardiomyopathy: implications for clinical management and prognosis. Eur Heart J (2009) 0.94
β-trace protein and cystatin C as predictors of long-term outcomes in patients with acute heart failure. J Am Coll Cardiol (2011) 0.93
Salmonella ovarian abscess following travel diarrhoea episode. Arch Gynecol Obstet (2007) 0.93
Serum levels of high-sensitivity troponin T: a novel marker for cardiac remodeling in hypertrophic cardiomyopathy. J Card Fail (2010) 0.93
Growth differentiation factor-15, a novel biomarker related with disease severity in patients with hypertrophic cardiomyopathy. Eur J Intern Med (2011) 0.92
Surgical treatment for multinodular goitres in geriatric patients. Langenbecks Arch Surg (2005) 0.92
Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure. Am J Cardiol (2009) 0.92
Value of serological testing for diagnosis of legionellosis in outbreak patients. J Clin Microbiol (2005) 0.92
Effects of 3 adhesion promoters on the shear bond strength of orthodontic brackets: an in-vitro study. Am J Orthod Dentofacial Orthop (2006) 0.91
Metformin protects against doxorubicin-induced cardiotoxicity: involvement of the adiponectin cardiac system. Free Radic Biol Med (2011) 0.90
Nosocomial candidemia at a general hospital: the change of epidemiological and clinical characteristics. A comparative study of 2 cohorts (1993-1998 versus 2002-2005). Rev Iberoam Micol (2009) 0.90
An atypical presentation of Tako-Tsubo cardiomyopathy. Int J Cardiol (2008) 0.90
A comparison of the shear bond strength of a resin cement and two orthodontic resin adhesive systems. Angle Orthod (2005) 0.89
Reproducibility of echocardiographic measurements of epicardial fat thickness. Int J Cardiol (2008) 0.89
High-sensitivity troponin T as a biomarker for the development of atrial fibrillation after cardiac surgery. Eur J Cardiothorac Surg (2013) 0.89
Biological dosimetry and Bayesian analysis of chromosomal damage in thyroid cancer patients. Radiat Prot Dosimetry (2007) 0.89
Insights into genotype-phenotype correlation in hypertrophic cardiomyopathy. Findings from 18 Spanish families with a single mutation in MYBPC3. Heart (2010) 0.89
Age-related changes in fatty acids from different adipose depots in rat and their association with adiposity and insulin. Nutrition (2008) 0.87
Predictive value of the CHA2DS2-VASc score in atrial fibrillation patients at high risk for stroke despite oral anticoagulation. Rev Esp Cardiol (Engl Ed) (2012) 0.87
Penetrance and risk profile in inherited cardiac diseases studied in a dedicated screening clinic. Am J Cardiol (2009) 0.87
Effect on oximetry of dyes used for sentinel lymph node biopsy. Arch Surg (2004) 0.86
Impact of kidney dysfunction on plasma and urinary N-terminal pro-B-type natriuretic peptide in patients with acute heart failure. Congest Heart Fail (2010) 0.86
[Clinical and Preclinical Heart Failure Research Network (REDINSCOR). Instituto de Salud Carlos III Cooperative Special Topic Research Networks]. Rev Esp Cardiol (2008) 0.86
Multidrug and carbapenem-resistant Acinetobacter baumannii infections: Factors associated with mortality. Med Clin (Barc) (2011) 0.86
Association analysis of MICA gene polymorphism and MICA-129 dimorphism with inflammatory bowel disease susceptibility in a Spanish population. Hum Immunol (2010) 0.86
Venous thromboembolism in women using hormonal contraceptives. Findings from the RIETE Registry. Thromb Haemost (2009) 0.86
[Orthopedic implant infection: prognostic factors and influence of long-term antibiotic treatment on evolution. Prospective study, 1992-1999]. Enferm Infecc Microbiol Clin (2003) 0.84
β-Trace protein: from GFR marker to cardiovascular risk predictor. Clin J Am Soc Nephrol (2013) 0.84
Unusual presentation of acute coronary syndrome. Bilateral coronary dissection after car accident. Am J Emerg Med (2009) 0.84
[Bacteraemia due to Escherichia coli producing extended-spectrum beta-lactamases (ESBL): clinical relevance and today's insights]. Rev Esp Quimioter (2011) 0.84
Soluble ST2 is a marker for acute cardiac allograft rejection. Ann Thorac Surg (2011) 0.84
In vitro study of force decay of latex and non-latex orthodontic elastics. Eur J Orthod (2011) 0.83
Effects of atorvastatin 80 mg daily on indices of matrix remodelling in 'high-risk' patients with ischemic heart disease. Int J Cardiol (2008) 0.83
Impact of chronic kidney disease on major bleeding complications and mortality in patients with indication for oral anticoagulation undergoing coronary stenting. Chest (2008) 0.83
Variables associated with contrast-enhanced cardiovascular magnetic resonance in hypertrophic cardiomyopathy: clinical implications. J Card Fail (2008) 0.83
Randomized comparison of sirolimus-eluting and everolimus-eluting coronary stents in the treatment of total coronary occlusions: results from the chronic coronary occlusion treated by everolimus-eluting stent randomized trial. Circ Cardiovasc Interv (2013) 0.83